(2R,5R)-1-((Benzyloxy)carbonyl)-4-(tert-butoxycarbonyl)-5-methylpiperazine-2-carboxylic acid

Catalog No. :
ACRXXO128
CAS No. :
1403898-75-8
Molecular Formula :
C19H26N2O6
Molecular Weight :
378.42

IUPAC Name:(2R,5R)-1-((benzyloxy)carbonyl)-4-(tert-butoxycarbonyl)-5-methylpiperazine-2-carboxylic acid

(2R,5R)-1-((Benzyloxy)carbonyl)-4-(tert-butoxycarbonyl)-5-methylpiperazine-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$456.00Login to see priceInquiryInquiry
1g98%$1006.00Login to see priceInquiryInquiry
5g98%$3320.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,5R)-1-((Benzyloxy)carbonyl)-4-(tert-butoxycarbonyl)-5-methylpiperazine-2-carboxylic acid
IUPAC Name(2R,5R)-1-((benzyloxy)carbonyl)-4-(tert-butoxycarbonyl)-5-methylpiperazine-2-carboxylic acid
Molecular FormulaC19H26N2O6
Molecular Weight378.42
SMILESO=C([C@@H]1N(C(OCC2=CC=CC=C2)=O)C[C@@H](C)N(C(OC(C)(C)C)=O)C1)O
InChI KeyJHIMTSADMKOTNY-UKRRQHHQSA-N
Synonym1,2,4-Piperazinetricarboxylic acid, 5-methyl-, 4-(1,1-dimethylethyl) 1-(phenylmethyl) ester, (2R,5R)-;(2R,5R)-1-((Benzyloxy)carbonyl)-4-(tert-butoxycarbonyl)-5-methylpiperazine-2-carboxylic acid;(2R, 5R)-5-Methyl-piperazine-1,2,4-tricarboxylic acid 1-benzyl ester 4-tert-butyl ester
CAS No.1403898-75-8

Synthetic Route by SureRoute

1. ACRXXO128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRXXO128 route product structure diagram
    ACRXXO1281403898-75-8
Inquiry

2. ACRXXO128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRXXO128 route product structure diagram
    ACRXXO1281403898-75-8
Inquiry

Comments (0)